This article will cover five key areas where you should be applying innovation and critical thinking to reimagine your pharmaceutical construction and capital projects.
The pharmaceutical construction sector is facing an inflection point. What was once a robust and predictably advancing market—often progressing toward net zero and state-of-the-art facilities as a matter of course—has been upended by a convergence of unpredictable costs, supply chain volatility, and global uncertainty. With tariffs topping 25% and material and labor costs rising just as sharply, project teams are facing what effectively feels like a 50% increase in overall expenses. This new environment demands a fundamental shift in how pharmaceutical construction is approached.
Rather than automatically moving forward with fully built-out net-zero facilities or over-customized fit-outs, developers, architects, and contractors are now being forced to distinguish between “needs” and “wants.” Critical thinking must be at the forefront—projects can no longer be justified based solely on prior assumptions.
This is why I’ve outlined the five key areas where you should be investing your time to deliver successful projects and ensure that progress continues, but is achieved with more efficiency and resilience than before.
El Sea has navigated many economic shifts and when we are guiding partners these are the critical questions we ask to get to the correct approach for that specific projects’ need.
El Sea has witnessed many shifts first hand over the past twenty-five years. Our journey through the trials and tribulations of the industry has equipped us with invaluable insights that have shaped our approach to these challenges for our Owners. Rather than automatically moving forward with fully built-out net-zero facilities or over-customized fit-outs, developers, architects, and contractors are now being forced to distinguish between “needs” and “wants.” Critical thinking must be at the forefront—projects can no longer be justified based solely on prior assumptions.
Drawing from El Sea’s extensive experience, we’ve outlined the five key areas where you refine requirements to show where it’s best to be investing your time to deliver successful projects in this new paradigm. Careful planning, innovative strategies, and smarter contracting approaches are essential to ensure that progress continues, but is achieved with more efficiency and resilience than before.
Understanding the New Cost Landscape
It’s not just inflation—it’s inflation compounded by geopolitical complexity, trade policy shifts, and lingering supply chain disruptions. A 25% increase in construction costs over the past 5 years. (5.85% year over year and in 2020/2021 a 20% materials cost increase alone)[6][7] coupled with recent tariffs proclamations of the same magnitude results in what feels like a 50% bump in project capital requirements. Pharmaceutical builds—already among the most complex and expensive in the construction sector—are particularly vulnerable. Cleanrooms, precise HVAC systems, specialized materials, and strict regulatory requirements are non-negotiable. So where can teams adapt?
This is where a strategic shift is necessary. Projects must now begin with a reassessment of scope and prioritization of core functional requirements over aspirational upgrades. That doesn’t mean abandoning sustainability or innovation, but it does mean rethinking how to achieve them.
Prefabrication and Modular Design as Strategic Tools
One of the most effective ways to mitigate costs and reduce schedule risk is by embracing prefabrication and modular design. These methods have long been valued for their efficiency, but they’ve become essential in today’s environment.
By manufacturing components off-site in controlled environments, prefabrication can help reduce labor costs, limit waste, and improve overall build quality. Modular cleanrooms, mechanical systems, and utility skids can be delivered just in time, slashing construction timelines and reducing the number of skilled trades required on-site.
Additionally, modularity provides built-in flexibility. Pharmaceutical companies facing uncertain demand or regulatory shifts can scale up or down more easily with modular infrastructure. Rather than betting the entire project budget on one static facility, they can stage investments and adjust plans as needed.
Smarter Contracting Vehicles and Risk-Sharing Models
Traditional design-bid-build approaches often encourage adversarial relationships and inefficiencies. In today’s high-risk environment, alternative project delivery methods that encourage early collaboration and shared accountability are proving more effective.
Integrated Project Delivery (IPD), Design-Build (DB), and Construction Manager at Risk (CMAR) models offer opportunities to bring all stakeholders—owners, designers, contractors, and key subcontractors—into the conversation earlier. This collaboration enables better forecasting, proactive risk management, and more transparent budgeting.
Savings-sharing clauses and performance-based incentives can further align interests. When contractors and design teams are rewarded for delivering under budget or ahead of schedule, innovation naturally follows. The collective focus shifts from protecting individual margins to delivering overall value.
Rethinking Sustainability Without Abandoning It
Cost pressures don’t have to mean sacrificing sustainability goals—but they may require reprioritization. Instead of building every facility to net-zero specifications from day one, teams can take a phased approach.
Value engineering can help identify systems or materials that deliver the greatest environmental impact for the lowest upfront cost. Lifecycle cost analysis, meanwhile, helps demonstrate that some sustainable investments (like high-efficiency HVAC or energy management systems) still pay off over time, even in today’s market.
Focusing on high-return sustainability wins—such as envelope performance, energy monitoring, or water-saving technologies—can help facilities stay on the path toward net zero without overextending budgets.
Leveraging Data and Digital Tools
Digital tools are another underutilized resource for cost containment. Building Information Modeling (BIM), digital twins, and advanced procurement platforms can all reduce project risk and improve coordination.
BIM enables teams to identify clashes, reduce errors, and streamline sequencing before construction begins. Digital twins support real-time monitoring, allowing for better operational planning once the facility is live. Procurement systems integrated with project management platforms can ensure that materials are ordered strategically—minimizing both lead times and exposure to price spikes.
When project teams have reliable data, they make better decisions. In a volatile climate, that’s not a luxury — it’s a necessity.
Critical Thinking as the Cornerstone
There’s no sugarcoating the current reality—pharmaceutical construction is more expensive and complex than ever. But with the right mindset, teams can still move projects forward.
Prefabrication, collaborative contracting, smart sustainability, and digital tools aren’t just helpful—they’re now essential. Most importantly, leaders must engage in critical thinking at every phase: defining priorities, aligning stakeholders, and building in flexibility wherever possible.
The projects that succeed in this era will not be the ones that stick to yesterday’s playbook. They will be the ones that embrace innovation, demand efficiency, and plan for uncertainty. In doing so, they’ll not only navigate today’s challenges—they’ll be better prepared for the ones yet to come.
- Understanding the New Cost Landscape: The pharmaceutical construction sector is indeed facing increased costs due to inflation, geopolitical complexities, and supply chain disruptions. A report highlights the impact of these factors on construction costs [1].
- Prefabrication and Modular Design as Strategic Tools: Prefabrication and modular design are effective strategies to mitigate costs and reduce schedule risks. These methods are increasingly valued for their efficiency and flexibility in the pharmaceutical industry [2].
- Smarter Contracting Vehicles and Risk-Sharing Models: Alternative project delivery methods like Integrated Project Delivery (IPD), Design-Build (DB), and Construction Manager at Risk (CMAR) are proving effective in today’s high-risk environment by encouraging early collaboration and shared accountability [3].
- Rethinking Sustainability Without Abandoning It: Sustainability remains a critical goal, but it requires reprioritization. Value engineering and lifecycle cost analysis can help identify high-return sustainability investments [4].
- Leveraging Data and Digital Tools: Digital tools such as Building Information Modeling (BIM), digital twins, and advanced procurement platforms are essential for cost containment and improving coordination in pharmaceutical construction [5].
References
[1] Emerging Trends in Pharmaceutical Facility Construction for 2024 – EIDA
[2] How pharmaceutical companies can speed up construction projects
[3] Pharma & Biotech | Turner Construction Company
[4] Why We All Need Critical Thinking | Pharmaceutical Engineering – ISPE
[5] Construction in the Pharmaceutical and Biotechnology Sector
[6] RLB Construction Cost Report North America Q1 2024
[7] A Look at the Price of Construction : U.S. Bureau of Labor Statistics
